MMedication Read More Eli Lilly Drug Retatrutide Clinical Trial ResultsDecember 17, 2025 Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become…
MMedication Read More Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event riskNovember 28, 2025 1. In this cohort study, dulaglutide, semaglutide, and tirzepatide demonstrated similar risks of gastrointestinal adverse events (AEs) in…
MMedication Read More Weight-loss drugs: From a trickle to a floodNovember 18, 2025 It’s been varyingly called the “fat shot”, “skinny jab” or “magic pill” by politicians and celebrities who’ve put…
MMedication Read More Loss of Appetite May Result in Loss of Margins for Swiggy, Zomato – outlookbusiness.comNovember 7, 2025 Loss of Appetite May Result in Loss of Margins for Swiggy, Zomato outlookbusiness.comThe discovery that launched a new wave…
BBreaking News Read More Skye Bioscience Shows 18.1% vs 49.8% Weight Regain in Phase 2November 5, 2025 Skye Bioscience (Nasdaq: SKYE) will present a late-breaking oral abstract…
HHealth Read More Prices of Ozempic vs Mounjaro vs Wegovy: How much they cost in the US, UK, India and around the world |November 2, 2025 Groundbreaking diabetes and weight loss drugs like Ozempic and Mounjaro are transforming treatment, offering significant weight loss. However,…
MMedication Read More Prices of Ozempic vs Mounjaro vs Wegovy: How much they cost in the US, UK, India and around the world |November 1, 2025 Groundbreaking diabetes and weight loss drugs like Ozempic and Mounjaro are transforming treatment, offering significant weight loss. However,…
MMedication Read More Karan Johar’s Ozempic joke: What you ought to know about weight loss drugOctober 23, 2025 Ozempic 101: Is it behind Karan Johar’s weight loss? Fact sheet for health enthusiasts on benefits and risks…
HHealth care Read More GLP-1s and eating disorders: What journalists need to know October 9, 2025 From “Ozempic face” to the latest celebrity confession, there’s no shortage of news about GLP-1s, which has become…
MMedication Read More Ozempic coming soon to India: What is it? Benefits, side effects and controversiesOctober 1, 2025 India’s drug controller, the Central Drugs Standard Control Organisation (CDSCO), approved Ozempic (semaglutide) on 26 September for use…
HHealth Read More Cheap, Copycat Ozempic Was Supposed to Go Away. It’s Still Everywhere.September 21, 2025 The copycat weight-loss drugs party was supposed to be over, but it’s still raging on. Because of shortages…
MMedication Read More Wegovy And Zepbound Cost Effective But They Could Break Drug BudgetsSeptember 11, 2025 The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative…